Marketing Agreement To Advance Gene Therapy Delivery And Analytics
02/06/2026 12:15
BRIEF-Solid Biosciences And Nanomosaic Announce Co-Marketing Agreement To Advance Gene Therapy Delivery And Analytics June 2 (Reuters) - Solid Biosciences Inc SLDB.O:
SOLID BIOSCIENCES AND NANOMOSAIC ANNOUNCE CO-MARKETING AGREEMENT TO ADVANCE GENE THERAPY DELIVERY AND ANALYTICS
Source text: ID:nPnbykWPKa
Further company coverage: SLDB.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Solid Biosciences
See all newsSolid Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Solid Biosciences Inc expected to post a loss of 48 cents a share - Earnings Preview
Solid Biosciences Q2 net loss widens on higher R&D costs
Marketing Agreement To Advance Gene Therapy Delivery And Analytics
Solid Biosciences Q1 net loss widens on higher R&D costs